Absci (ABSI) Payables (2020 - 2026)
Absci (ABSI) posted Payables of $17.7 million for Q1 2026, down 12.35% sequentially from $20.2 million in Q4 2025, and up 136.59% YoY from $7.5 million in Q1 2025.
Absci (ABSI) Payables (2020 - 2026) Analysis & Trends
Absci has reported Payables for 7 years, with the latest figure at $17.7 million in Q1 2026.
- Quarterly Payables rose 136.59% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.7 million (up 136.59% YoY) and the FY2025 annual result came in at $20.2 million, up 53.4% from the prior year.
- Payables fell to $17.7 million in Q1 2026 per ABSI's latest filing, from $20.2 million in the prior quarter.
- Over five years, Payables peaked at $20.2 million in Q4 2025 and troughed at $4.2 million in Q3 2022.
- A 5-year average of $8.0 million and a median of $5.4 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables plunged 51.98% in 2022, then surged 176.87% in 2024.
- Over 5 years, Payables stood at $5.4 million in 2022, then fell by 11.14% to $4.8 million in 2023, then soared by 176.87% to $13.2 million in 2024, then soared by 53.4% to $20.2 million in 2025, then declined by 12.35% to $17.7 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $17.7 million, $20.2 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 16.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.41 Mn |
| Mar 31, 2026 | 17.72 Mn |
| Dec 31, 2025 | 20.22 Mn |
| Sep 30, 2025 | 5.89 Mn |
| Jun 30, 2025 | 10.19 Mn |
| Mar 31, 2025 | 7.49 Mn |
| Dec 31, 2024 | 13.18 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.95 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | 5.12 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 4.21 Mn |
| Jun 30, 2022 | 7.61 Mn |
| Mar 31, 2022 | 9.14 Mn |
| Dec 31, 2021 | 10.79 Mn |
| Sep 30, 2021 | 8.77 Mn |